According to the “Expert Statement on Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors”, NT-proBNP is the most useful biomarker to screen for cardiac involvement in patients with carcinoid syndrome (Evidence Level 2 to 3, Grade B). The gene discussed is NPPB; the disease is carcinoid heart disease.